161 related articles for article (PubMed ID: 26064876)
1. Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.
Roberts NW; Holley-Cuthrell J; Gonzalez-Vega M; Mull AJ; Heydemann A
Biomed Res Int; 2015; 2015():131436. PubMed ID: 26064876
[TBL] [Abstract][Full Text] [Related]
2. Genetic background influences muscular dystrophy.
Heydemann A; Huber JM; Demonbreun A; Hadhazy M; McNally EM
Neuromuscul Disord; 2005 Oct; 15(9-10):601-9. PubMed ID: 16084087
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
4. Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy.
Dye WW; Gleason RL; Wilson E; Humphrey JD
J Appl Physiol (1985); 2007 Aug; 103(2):664-72. PubMed ID: 17525297
[TBL] [Abstract][Full Text] [Related]
5. Common pathological mechanisms in mouse models for muscular dystrophies.
Turk R; Sterrenburg E; van der Wees CG; de Meijer EJ; de Menezes RX; Groh S; Campbell KP; Noguchi S; van Ommen GJ; den Dunnen JT; 't Hoen PA
FASEB J; 2006 Jan; 20(1):127-9. PubMed ID: 16306063
[TBL] [Abstract][Full Text] [Related]
6. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
Gawlik KI; Holmberg J; Durbeej M
Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
[TBL] [Abstract][Full Text] [Related]
7. Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy.
Chrzanowski SM; Vohra RS; Lee-McMullen BA; Batra A; Spradlin RA; Morales J; Forbes S; Vandenborne K; Barton ER; Walter GA
Mol Imaging; 2017; 16():1536012117732439. PubMed ID: 29271299
[TBL] [Abstract][Full Text] [Related]
8. Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.
Goldstein JA; Bogdanovich S; Beiriger A; Wren LM; Rossi AE; Gao QQ; Gardner BB; Earley JU; Molkentin JD; McNally EM
Hum Mol Genet; 2014 Dec; 23(25):6722-31. PubMed ID: 25070948
[TBL] [Abstract][Full Text] [Related]
9. Effect of genetic background on the dystrophic phenotype in mdx mice.
Coley WD; Bogdanik L; Vila MC; Yu Q; Van Der Meulen JH; Rayavarapu S; Novak JS; Nearing M; Quinn JL; Saunders A; Dolan C; Andrews W; Lammert C; Austin A; Partridge TA; Cox GA; Lutz C; Nagaraju K
Hum Mol Genet; 2016 Jan; 25(1):130-45. PubMed ID: 26566673
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.
Verhaart IE; van Duijn RJ; den Adel B; Roest AA; Verschuuren JJ; Aartsma-Rus A; van der Weerd L
Neuromuscul Disord; 2012 May; 22(5):418-26. PubMed ID: 22209498
[TBL] [Abstract][Full Text] [Related]
11. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
12. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
13. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
14. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
[TBL] [Abstract][Full Text] [Related]
15. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo.
Cassano M; Dellavalle A; Tedesco FS; Quattrocelli M; Crippa S; Ronzoni F; Salvade A; Berardi E; Torrente Y; Cossu G; Sampaolesi M
Development; 2011 Oct; 138(20):4523-33. PubMed ID: 21903674
[TBL] [Abstract][Full Text] [Related]
16. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.
Briguet A; Courdier-Fruh I; Foster M; Meier T; Magyar JP
Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425
[TBL] [Abstract][Full Text] [Related]
17. Xenotransplantation of embryonic precursors of human myogenesis for the correction of dystrophinopathy in mice with hereditary muscular dystrophy.
Yarygin VN; Sukhikh GT; Sitnikov VF; Stenina MA; Kuznetsov AB; Poltavtseva RA; Krivov LI; Voevodin DA; Savchuk VI; Revishchin AV; Korochkin LI; Aleksandrova MA
Bull Exp Biol Med; 2003 Jul; 136(1):88-92. PubMed ID: 14534620
[TBL] [Abstract][Full Text] [Related]
18. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
19. [Molecular basis of inherited muscular diseases].
Takeda S
No To Shinkei; 1995 Aug; 47(8):735-48. PubMed ID: 7546918
[No Abstract] [Full Text] [Related]
20. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
